These findings reveal the impact of ginsenoside Rg3 on DNA damage and downregulating PD-L1, and it opens a new window for developing new drugs based on ginsenoside Rg3 and presents a foundation for developing new therapeutic strategies for cancers. Here, CD274 is linked to cancer.